Trials / Completed
CompletedNCT01798160
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Selective Internal Radiation Therapy is superior to Transarterial Chemoembolisation for the treatment of intermediate stage hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | DEB TACE | DEB TACE every 6 weeks until either no viable tumor or endpoint reached. |
| PROCEDURE | SIRT | Selective Internal Radiation Therapy once at the beginning of the study. Follow up until endpoint. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2013-02-25
- Last updated
- 2015-10-20
Source: ClinicalTrials.gov record NCT01798160. Inclusion in this directory is not an endorsement.